Charles Schwab Investment Management Inc Axsome Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 356,651 shares of AXSM stock, worth $46.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
356,651
Previous 337,246
5.75%
Holding current value
$46.9 Million
Previous $39.3 Million
5.35%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding AXSM
# of Institutions
407Shares Held
37.4MCall Options Held
507KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA3.95MShares$519 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$434 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$222 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$200 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$150 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.64B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...